Current Genmab A/S forecasts and price targets in August 2026
Ø Analyst Price Targets
342.40 USD
+34.84 %
Median
355.52 USD
+40.01 %
Max
3,167.85 USD
Min
1,313.00 USD
Last Price
253.93 USD
Buy
16
Hold
8
Sell
2
The average target price for Genmab A/S is 342.40 USD. (+34.84 % above the current price)
The median price target of Genmab A/S is 355.52 USD.
Stock analysts from many renowned investment banks are closely examining the Genmab A/S stock. They conclude their professional Genmab A/S stock analyses with a clear recommendation for the Genmab A/S stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-04-01 | 17 | 8 | 2 | — |
| 2026-03-01 | 16 | 8 | 2 | 342.40 USD |
| 2026-02-01 | 16 | 8 | 2 | 352.22 USD |
| 2026-02-01 | 16 | 8 | 2 | 341.94 USD |
| 2026-01-01 | 16 | 9 | 2 | 333.96 USD |
| 2025-12-01 | 17 | 8 | 2 | 328.87 USD |
Genmab A/S Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Genmab A/S in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 4.37 B USD | 710.00 M USD | 11.33 USD |
| 2027e | 5.15 B USD | 1.05 B USD | 16.78 USD |
| 2028e | 6.22 B USD | 1.56 B USD | 24.93 USD |